Wuhan Wuyao Pharmaceutical Co.,_Intermediate_Food

With scientific thinking, international vision, professional management

Let Broad Medicine become the leader of API manufacturing

WITH SCIENTIFIC THINKING, INTERNATIONAL PERSPECTIVES AND PROFESSIONAL MANAGEMENT GRAND PHARMA AIMS TO BECOME THE LEADER IN THE MANUFACTURING OF APIS.

Wuhan Wuyao Pharmaceutical Co., Ltd.

Wuhan Wuyao Pharmaceutical Co., Ltd. is a holding subsidiary invested by Yuanda (China) Co., Ltd. (formerly Wuhan Pharmaceutical Factory) in 2002. It is a well-known enterprise in the production and operation of characteristic raw materials in China. The company passed the acceptance of "safety production standardization secondary enterprise"; in the same year, it was rated as "high-tech enterprise" in Hubei Province; the annual sales revenue was 0.6 billion yuan, and the products were exported to more than 40 countries and regions such as Europe and the United States, with an annual export value of 50 million US dollars.

According to the Wuhan Municipal People's Government's "Opinions on Accelerating the Relocation and Remediation of Chemical Production Enterprises in the Third Ring Road of Our City" (Wu Zheng [2008] No. 50) and the overall plan, Wuhan Wuyao Pharmaceutical Co., Ltd. moved to Hubei Province as a whole. Chemical Industrial Park, Fuchi Town, Yangxin County, Huangshi City. The company has 820 employees and 500 technical and management personnel above junior college. With a registered capital of 61 million yuan, the company is a high-tech enterprise engaged in the production and operation of raw materials.

MORE ⇀